Use of Anesthetic Agents in Neonates and Young Children
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Some drugs used for sedation and anesthesia produce histopathologic central nervous system changes in juvenile animal models. These observations have raised concerns regarding the use of these drugs in pediatric patients. We summarized the findings in developing animals and describe the steps that the Food and Drug Administration (FDA) and others are taking to assess potential risks in pediatric patients. The FDA views this communication as opening a dialog with the anesthesia community to address this issue. METHODS: We reviewed the available animal studies literature examining the potential neurotoxic effects of commonly used anesthetic drugs on the developing brain. The search strategy involved crossing the keywords neurotoxic and neuroapoptosis with the following general and specific terms: anesthetic, N-methyl-d-aspartate (NMDA), ketamine, midazolam, lorazepam, fentanyl, methadone, morphine, meperidine, isoflurane, nitrous oxide, sevoflurane, halothane, enflurane, desflurane, propofol, etomidate, barbiturate, methoxyflurane, and chloral hydrate. We summarized several studies sponsored by the FDA in rats and monkeys, initially examining the potential for ketamine, as a prototypical agent, to induce neurodegeneration in the developing brain. RESULTS: Numerous animal studies in rodents indicate that NMDA receptor antagonists, including ketamine, induce neurodegeneration in the developing brain. The effects of ketamine are dose dependent. The data suggest that limiting exposure limits the potential for neurodegeneration. There is also evidence that other general anesthetics, such as isoflurane, can induce neurodegeneration in rodent models, which may be exacerbated by concurrent administration of midazolam or nitrous oxide. There are very few studies that have examined the potential functional consequences of the neurodegeneration noted in the animal models. However, the studies that have been reported suggest subtle, but prolonged, behavioral changes in rodents. Although the doses and durations of ketamine exposure that resulted in neurodegeneration were slightly larger than those used in the clinical setting, those associated with isoflurane were not. There are insufficient human data to either support or refute the clinical applicability of these findings. CONCLUSIONS: Animal studies suggest that neurodegeneration, with possible cognitive sequelae, is a potential long-term risk of anesthetics in neonatal and young pediatric patients. The existing nonclinical data implicate not only NMDA-receptor antagonists, but also drugs that potentiate gamma-aminobutyric acid signal transduction, as potentially neurotoxic to the developing brain. The potential for the combination of drugs that have activity at both receptor systems or that can induce more or less neurotoxicity is not clear; however, recent nonclinical data suggest that some combinations may be more neurotoxic than the individual components. The lack of information to date precludes the ability to designate any one anesthetic agent or regimen as safer than any other. Ongoing studies in juvenile animals should provide additional information regarding the risks. The FDA anticipates working with the anesthesia community and pharmaceutical industry to develop strategies for further assessing the safety of anesthetics in neonates and young children, and for providing data to guide clinicians in making the most informed decisions possible when choosing anesthetic regimens for their pediatric patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rice, D., & Barone, S. (2000) · Environmental Health Perspectives · doi:10.1289/ehp.00108s3511 · Cited by 2,944 · cited 1×
“The period of synaptogenesis during which rodents appear to be most vulnerable to the anesthetic-associated neurodegeneration corresponds to human development that occurs approximately from the third trimester in utero through approximately the third year of life (24); however these cutoffs are only estimates.”
BackgroundBlockade of NMDA Receptors and Apoptotic Neurodegeneration in the Developing Brain
Ikonomidou, C., Bosch, F., Miksa, M., Bittigau, P., Vöckler, J., Dikranian, K., Tenkova, T. I., Stefovska, V., Turski, L., & Olney, J. W. (1999) · Science · doi:10.1126/science.283.5398.70 · Cited by 2,055
Jevtovic-Todorovic, V., Hartman, R. E., Izumi, Y., Benshoff, N. D., Dikranian, K., Zorumski, C. F., Olney, J. W., & Wozniak, D. F. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-03-00876.2003 · Cited by 1,983
Ethanol-Induced Apoptotic Neurodegeneration and Fetal Alcohol Syndrome
Ikonomidou, C., Bittigau, P., Ishimaru, M. J., Wozniak, D. F., Koch, C., Genz, K., Price, M. T., Stefovska, V., Hörster, F., Tenkova, T., et al. (2000) · Science · doi:10.1126/science.287.5455.1056 · Cited by 1,371
Antiepileptic drugs and apoptotic neurodegeneration in the developing brain
Bittigau, P., Sifringer, M., Genz, K., Reith, E., Pospischil, D., Govindarajalu, S., Dzietko, M., Pesditschek, S., Mai, I., Dikranian, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222550499 · Cited by 779
Gill, R., Foster, A., & Woodruff, G. (1987) · The Journal of Neuroscience · doi:10.1523/jneurosci.07-10-03343.1987 · Cited by 640
Young, C., Jevtovic‐Todorovic, V., Qin, Y., Tenkova, T., Wang, H., Labruyere, J., & Olney, J. W. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706301 · Cited by 476
General anaesthetic actions on ligand-gated ion channels
Krasowski, M. D., & Harrison, N. L. (1999) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180050371 · Cited by 384 · cited 2×
“and Harrison (9) and by Dilger (10); for more detail, please refer these review articles.”
BackgroundProtective Effect of the Glutamate Antagonist, MK-801 in Focal Cerebral Ischemia in the Cat
Ozyurt, E., Graham, D. I., Woodruff, G. N., & McCulloch, J. (1988) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1988.18 · Cited by 368
Scallet, A. C. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh224 · Cited by 299
Drug‐induced Apoptotic Neurodegeneration in the Developing Brain
Olney, J. W., Wozniak, D. F., Jevtovic‐Todorovic, V., Farber, N. B., Bittigau, P., & Ikonomidou, C. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00467.x · Cited by 298
Ikonomidou, C., Bittigau, P., Koch, C., Genz, K., Hoerster, F., Felderhoff-Mueser, U., Tenkova, T., Dikranian, K., & Olney, J. W. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00696-7 · Cited by 296
Neurogenesis in adolescent brain is potently inhibited by ethanol
Crews, F. T., Mdzinarishvili, A., Kim, D., He, J., & Nixon, K. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.08.090 · Cited by 265 · cited 1×
“In addition, there is a second period of accelerated synaptogenesis that occurs during adolescence, and there is some evidence suggesting an increased neurological vulnerability to the effects of alcohol and certain drugs used recreationally during this time period (25).”
BackgroundMK-801 protects the neonatal brain from hypoxic-ischemic damage
McDonald, J. W., Silverstein, F. S., & Johnston, M. V. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90295-0 · Cited by 256
Neurofunctional deficits and potentiated apoptosis by neonatal NMDA antagonist administration
Fredriksson, A., Archer, T., Alm, H., Gordh, T., & Eriksson, P. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.12.026 · Cited by 241
Pohl, D., Bittigau, P., Ishimaru, M. J., Stadthaus, D., Hübner, C., Olney, J. W., Turski, L., & Ikonomidou, C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2508 · Cited by 236
Ontogeny of the N-Methyl-D-Aspartate (NMDA) Receptor System and Susceptibility to Neurotoxicity
Haberny, K. A. (2002) · Toxicological Sciences · doi:10.1093/toxsci/68.1.9 · Cited by 219
Foster, A., Gill, R., & Woodruff, G. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-12-04745.1988 · Cited by 214
The role of the N-methyl-d-aspartate receptor in ketamine-induced apoptosis in rat forebrain culture
Wang, C., Sadovova, N., Fu, X., Schmued, L., Scallet, A., Hanig, J., & Slikker, W. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.01.053 · Cited by 190
Wang, C., Sadovova, N., Hotchkiss, C., Fu, X., Scallet, A. C., Patterson, T. A., Hanig, J., Paule, M. G., & Slikker, W. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj144 · Cited by 187
Anesthetic Agents and the Immature Brain: Are These Toxic or Therapeutic?
Anand, K. J. S., & Soriano, S. G. (2004) · Anesthesiology · doi:10.1097/00000542-200408000-00033 · Cited by 176
Repeated administration of ketamine may lead to neuronal degeneration in the developing rat brain
HAYASHI, H., DIKKES, P., & SORIANO, S. G. (2002) · Pediatric Anesthesia · doi:10.1046/j.1460-9592.2002.00883.x · Cited by 174
Anesthesia-induced Developmental Neuroapoptosis: Does It Happen in Humans?
Olney, J. W., Young, C., Wozniak, D. F., Ikonomidou, C., & Jevtović‐Todorović, V. (2004) · Anesthesiology · doi:10.1097/00000542-200408000-00004 · Cited by 159
FADEN, A. I., LEMKE, M., SIMON, R. P., & NOBLE, L. J. (1988) · Journal of Neurotrauma · doi:10.1089/neu.1988.5.33 · Cited by 159
MK-801 prevents hypobaric-ischemic neuronal degeneration in infant rat brain
Olney, J., Ikonomidou, C., Mosinger, J., & Frierdich, G. (1989) · The Journal of Neuroscience · doi:10.1523/jneurosci.09-05-01701.1989 · Cited by 159
Do pediatric drugs cause developing neurons to commit suicide?
Olney, J. W., Young, C., Wozniak, D. F., Jevtović‐Todorović, V., & Ikonomidou, C. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.01.002 · Cited by 153
Jevtović‐Todorović, V., Benshoff, N. D., & Olney, J. W. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703479 · Cited by 119
Solt, K., Eger, E. I., & Raines, D. E. (2006) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000204252.07406.9f · Cited by 99
Callahan, R. J., Au, J. D., Paul, M., Liu, C., & Yost, C. S. (2004) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000099723.75548.df · Cited by 95
The effects of general anaesthetics on ligand-gated ion channels
Dilger, J. P. (2002) · British Journal of Anaesthesia · doi:10.1093/bja/aef161 · Cited by 90
SINGLE-DOSE KETAMINE ADMINISTRATION INDUCES APOPTOSIS IN NEONATAL MOUSE BRAIN
Rudin, M., Ben‐Abraham, R., Gazit, V. A., Tendler, Y., Tashlykov, V., & Katz, Y. S. (2005) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp.2005.16.4.231 · Cited by 82
N‐メチル‐D‐アスパラギン酸きっ抗薬と発達ラット脳における頭部外傷により引き起こされるアポトーシス細胞死
Pohl, D., Bittigau, P., Ishimaru, M. J., Stadthaus, D., Huebner, C., Olney, J. W., Turski, L., & Ikonomidou, C. (1999) · Cited by 78
Of Mice and Men: Should We Extrapolate Rodent Experimental Data to the Care of Human Neonates?
Soriano, S. G., Anand, K. J. S., Rovnaghi, C. R., & Hickey, P. R. (2005) · Anesthesiology · doi:10.1097/00000542-200504000-00030 · Cited by 70
Neurobehavioral Assessment: A Survey of Use and Value in Safety Assessment Studies
Middaugh, L. D., Dow-Edwards, D. L., Li, A. A., Sandler, J. D., Seed, J. G., Sheets, L. P., Shuey, D. L., Slikker, W., Weisenburger, W. P., Wise, L. D., et al. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg211 · Cited by 43
Stringer, M. G., Makin, M. K., Miles, J., & Morley, J. S. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01573-1 · Cited by 40
Cited by
Early Exposure to Anesthesia and Learning Disabilities in a Population-based Birth Cohort
Wilder, R. T., Flick, R. P., Sprung, J., Katusic, S. K., Barbaresi, W. J., Mickelson, C., Gleich, S. J., Schroeder, D. R., Weaver, A. L., & Warner, D. O. (2009) · Anesthesiology · doi:10.1097/01.anes.0000344728.34332.5d · Cited by 1,364
Sun, L. S., Li, G., Miller, T. L. K., Salorio, C., Byrne, M. W., Bellinger, D. C., Ing, C., Park, R., Radcliffe, J., Hays, S. R., et al. (2016) · JAMA · doi:10.1001/jama.2016.6967 · Cited by 949
Ketamine Pharmacology: An Update ( Pharmacodynamics and Molecular Aspects, Recent Findings )
Mion, G., & Villevieille, T. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12099 · Cited by 711
“The existing experimental data implicate not only NMDA receptor antagonists, but also drugs that potentiate gamma-aminobutyric acid signal transduction, as potentially neurotoxic to the developing brain [146].”
BackgroundKetamine-Induced Neuronal Cell Death in the Perinatal Rhesus Monkey
Slikker, W., Zou, X., Hotchkiss, C. E., Divine, R. L., Sadovova, N., Twaddle, N. C., Doerge, D. R., Scallet, A. C., Patterson, T. A., Hanig, J. P., et al. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm084 · Cited by 608
Paule, M. G., Li, M., Allen, R. R., Liu, F., Zou, X., Hotchkiss, C., Hanig, J. P., Patterson, T. A., Slikker, & Wang, C. (2011) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2011.01.001 · Cited by 574
Metadata
- Authors
- Mellon, R. D., Simone, A. F., & Rappaport, B. A.
- Venue
- Anesthesia & Analgesia
- Published
- 2007-03
- Volume
- 104
- Issue
- 3
- Pages
- 509-520
- ISSN
- 0003-2999 (ISSN-L)
- OpenAlex
- W2012968801
- Cited by
- 399
- References
- 35
- FWCI
- 9.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.